- Review article: Diagnosis and investigation of irritable . . .
The yield of routine blood tests in suspected IBS is low overall, but normal inflammatory markers may be reassuring All patients should have serological testing for coeliac disease, irrespective of their predominant stool form
- Rational investigations in irritable bowel syndrome - PMC
Routine blood tests in suspected IBS have low yield, but are an acceptable part of routine practice All patients should have coeliac serology tested, regardless of their predominant stool form
- Rational investigations in irritable bowel syndrome
Routine blood tests in suspected IBS have low yield, but are an acceptable part of routine practice All patients should have coeliac serology tested, regardless of their predominant stool form
- Full article: An evidence-based update on the diagnosis and . . .
We searched the literature for diagnostic accuracy studies, randomized controlled trials, and meta-analyses A positive diagnosis of IBS, alongside testing to exclude celiac disease, is recommended Exhaustive investigation has a low yield Patients should be offered traditional dietary advice
- Evidence- and Consensus-Based Practice Guidelines for the . . .
Irritable bowel syndrome diagnostic algorithm for gastrointestinal subspecialty workup (module 2) CBC indicates complete blood cell count; ESR, erythrocyte sedimentation rate; TSH, thyrotropin (thyroid-stimulating hormone) level; FOBT, fecal occult blood test; and EMG, electromyography
- Irritable bowel syndrome: Pathogenesis, diagnosis, treatment . . .
According to the updated ROME III criteria, IBS is a clinical diagnosis and presents as one of the three predominant subtypes: (1) IBS with constipation (IBS-C); (2) IBS with diarrhea (IBS-D); and (3) mixed IBS (IBS-M); former ROME definitions refer to IBS-M as alternating IBS (IBS-A)
|